I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 63% ± 13% | |
| deuterosomal cell | 4 studies | 27% ± 5% | |
| ependymal cell | 3 studies | 81% ± 10% | |
| astrocyte | 3 studies | 26% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 63% ± 13% | |
| deuterosomal cell | 4 studies | 27% ± 5% | |
| ependymal cell | 3 studies | 81% ± 10% | |
| astrocyte | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of ARMC3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 81% | 216.65 | 2149 / 2642 | 22% | 1.28 | 154 / 705 |
| lung | 70% | 345.75 | 404 / 578 | 33% | 1.40 | 377 / 1155 |
| kidney | 73% | 45.24 | 65 / 89 | 26% | 0.75 | 234 / 901 |
| pancreas | 73% | 26.24 | 240 / 328 | 13% | 0.50 | 23 / 178 |
| ovary | 10% | 5.79 | 18 / 180 | 69% | 3.78 | 296 / 430 |
| breast | 6% | 3.18 | 28 / 459 | 40% | 1.32 | 452 / 1118 |
| uterus | 19% | 92.28 | 33 / 170 | 21% | 2.03 | 97 / 459 |
| prostate | 18% | 11.92 | 43 / 245 | 13% | 0.37 | 65 / 502 |
| thymus | 20% | 11.96 | 133 / 653 | 1% | 0.06 | 7 / 605 |
| esophagus | 2% | 0.90 | 33 / 1445 | 8% | 0.22 | 15 / 183 |
| intestine | 7% | 2.05 | 68 / 966 | 3% | 0.15 | 18 / 527 |
| stomach | 0% | 0.09 | 1 / 359 | 5% | 0.12 | 14 / 286 |
| peripheral blood | 4% | 2.81 | 40 / 929 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 4% | 0.14 | 20 / 504 |
| skin | 0% | 0.33 | 9 / 1809 | 3% | 0.08 | 16 / 472 |
| liver | 0% | 0.19 | 1 / 226 | 3% | 0.09 | 12 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| heart | 1% | 0.31 | 10 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 0.40 | 15 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 1% | 0.68 | 8 / 803 | 0% | 0 | 0 / 0 |
| adipose | 1% | 0.24 | 8 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.11 | 1 / 258 | 0% | 0 | 0 / 230 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007286 | Biological process | spermatid development |
| GO_0030317 | Biological process | flagellated sperm motility |
| GO_0034517 | Biological process | ribophagy |
| GO_0070062 | Cellular component | extracellular exosome |
| Gene name | ARMC3 |
| Protein name | Armadillo repeat containing 3 Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1) |
| Synonyms | |
| Description | FUNCTION: Essential for male fertility and sperm motility (By similarity). During spermatogenesis, promotes the autophagic degradation of excessive ribosomes, providing energy resources for mitochondria and thus ensuring sperm flagellar motility . . |
| Accessions | ENST00000409049.7 [Q5W041-3] ENST00000409983.7 [Q5W041-4] C9JC46 B4DXS3 ENST00000376528.8 ENST00000298032.10 [Q5W041-2] ENST00000447081.5 Q5W041 |
